
ABK Biomedical Completes Enrollment in ROUTE90 Pivotal Study for Primary Liver Cancer
HALIFAX, NS, Feb. 24, 2026 /PRNewswire/ – ABK Biomedical, Inc., an innovative, medical device company dedicated to the research, development, and commercialization of advanced imageable embolic medical devices, today announced the completion…